Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
| Autor: | Lorusso, D. *, Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F., Ferrandina, G. |
|---|---|
| Zdroj: | In Annals of Oncology March 2016 27(3):487-493 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|